- Home
- NEPH vs HOOK Comparison
NEPH vs HOOK Comparison
Compare NEPH & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEPH
- HOOK
- Stock Information
- Founded
- NEPH 1997
- HOOK 2011
- Country
- NEPH United States
- HOOK United States
- Employees
- NEPH N/A
- HOOK N/A
- Industry
- NEPH Medical/Dental Instruments
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- NEPH Health Care
- HOOK Health Care
- Exchange
- NEPH Nasdaq
- HOOK Nasdaq
- Market Cap
- NEPH 16.8M
- HOOK 18.1M
- IPO Year
- NEPH 2004
- HOOK 2019
- Fundamental
- Price
- NEPH $1.90
- HOOK $0.75
- Analyst Decision
- NEPH Buy
- HOOK Buy
- Analyst Count
- NEPH 1
- HOOK 4
- Target Price
- NEPH $5.00
- HOOK $10.67
- AVG Volume (30 Days)
- NEPH 14.3K
- HOOK 41.3K
- Earning Date
- NEPH 05-08-2025
- HOOK 05-08-2025
- Dividend Yield
- NEPH N/A
- HOOK N/A
- EPS Growth
- NEPH N/A
- HOOK N/A
- EPS
- NEPH 0.01
- HOOK N/A
- Revenue
- NEPH $14,162,000.00
- HOOK $43,946,000.00
- Revenue This Year
- NEPH $9.23
- HOOK N/A
- Revenue Next Year
- NEPH $12.99
- HOOK N/A
- P/E Ratio
- NEPH $270.27
- HOOK N/A
- Revenue Growth
- NEPH N/A
- HOOK 118.32
- 52 Week Low
- NEPH $1.36
- HOOK $0.72
- 52 Week High
- NEPH $2.55
- HOOK $10.50
- Technical
- Relative Strength Index (RSI)
- NEPH 59.12
- HOOK 21.32
- Support Level
- NEPH $1.66
- HOOK $0.72
- Resistance Level
- NEPH $2.22
- HOOK $0.88
- Average True Range (ATR)
- NEPH 0.13
- HOOK 0.09
- MACD
- NEPH 0.02
- HOOK -0.02
- Stochastic Oscillator
- NEPH 54.93
- HOOK 5.48
Stock Price Comparison Chart: NEPH vs HOOK
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.